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ABSTRACT
DNA methylation plays critical roles in transcrip-
tional regulation and chromatin remodeling.
Differentially methylated regions (DMRs) have im-
portant implications for development, aging and
diseases. Therefore, genome-wide mapping of
DMRs across various temporal and spatial methyl-
omes is important in revealing the impact of epigen-
etic modifications on heritable phenotypic variation.
We present a quantitative approach, quantitative
differentially methylated regions (QDMRs), to quan-
tify methylation difference and identify DMRs from
genome-wide methylation profiles by adapting
Shannon entropy. QDMR was applied to synthetic
methylation patterns and methylation profiles
detected by methylated DNA immunoprecipitation
microarray (MeDIP-chip) in human tissues/cells.
This approach can give a reasonable quantitative
measure of methylation difference across multiple
samples. Then DMR threshold was determined
from methylation probability model. Using this
threshold, QDMR identified 10651 tissue DMRs
which are related to the genes enriched for cell dif-
ferentiation, including 4740 DMRs not identified by
the method developed by Rakyan et al. QDMR can
also measure the sample specificity of each DMR.
Finally, the application to methylation profiles
detected by reduced representation bisulphite se-
quencing (RRBS) in mouse showed the platform-
free and species-free nature of QDMR. This
approach provides an effective tool for the high-
throughput identification of potential functional
regions involved in epigenetic regulation.
INTRODUCTION
DNA methylation, as a natural and inheritable epigenetic
event, affects biological phenotype by inhibiting gene ex-
pression without changing the DNA sequence (1). The
quantiﬁcation of methylation difference across large
numbers of samples and the identiﬁcation of sample-
speciﬁcity are important in genomic function analysis,
and may provide an important reference for identifying
speciﬁc drug targets. Differentially methylated regions
(DMRs), as genomic regions with different methylation
statuses among multiple samples (tissues, cells, individuals
or others), are regarded as possible functional regions
involved in gene transcriptional regulation. The identiﬁca-
tion of DMRs among multiple tissues (T-DMRs) provides
a comprehensive survey of epigenetic differences among
human tissues (2). DMRs between cancer and normal
samples (C-DMRs) demonstrate the aberrant methylation
in cancers (3). It is well known that DNA methylation is
associated with cell differentiation and proliferation (4).
Many DMRs have been found in the development
stages (D-DMRs) (5) and in the reprogrammed progress
(R-DMRs) (6). In addition, there are intra-individual
DMRs (Intra-DMRs) with longitudinal changes in
global DNA methylation along with the increase of age
in a given individual (7). There are also inter-individual
DMRs (Inter-DMRs) with different methylation patterns
among multiple individuals (8).
With the progress of DNA sequencing technologies,
DNA methylation proﬁling techniques have undergone a
veritable revolution over the past decade (9). Several tech-
niques have been developed for proﬁling DNA methyla-
tion patterns across various cells or tissues. In the earliest
studies, tissue-speciﬁc DNA methylation in a few genes
was detected by restriction enzymes (10) or restriction
landmark genomic scanning (RLGS) method (11). But
these methods are subject to restriction enzyme sites and
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ery of pre-treatment with sodium bisulphite chemically
spurred a revolution in high sensitivity mapping of
methylated cytosines (12). This approach has been widely
applied in various methylation mapping projects including
human epigenome project (HEP) (13). However, it is
prohibitively expensive for genome-wide applications.
To circumvent these limitations, Weber et al. (14) de-
veloped methylated DNA immunoprecipitation (MeDIP),
which utilizes antibody against 5-methylcytosine to enrich
methylated DNA. MeDIP, in combination with oligo-
nucleotide arrays (MeDIP-chip) becomes a powerful
approach for DNA methylation proﬁling (2,15). With the
recent advances of next-generation sequencing techniques,
several sequencing-based techniques, including bisulphite-
based techniques MethylC-Seq (16) and reduced represen-
tation bisulphite sequencing (RRBS) (17), and enrichment-
based methods MeDIP sequencing (MeDIP-seq) (18) and
MBD-isolated Genome Sequencing (MiGS) (19) and
enzyme-based techniques methyl-sensitive cut counting
(MSCC) (20) and methylation mapping analysis by
paired-end sequencing (Methyl-MAPS) (21), have been
developedforthegenome-widestudyofDNAmethylation.
In most of current methylation mapping techniques,
the original or pretreated DNA methylation status is rep-
resented by continuous values with measurement scale
from 0 to 1 (22). The unprecedented scale and precision
of data have enabled the quantitative analysis of differen-
tialDNAmethylationstatusingeneregulationacrosscells/
tissues (23).
With high throughput technologies over recent years,
there have been considerable efforts in identifying
DMRs from experimental proﬁles produced by speciﬁc
methylation proﬁling techniques. Bibikova et al.
compared the difference in mean methylation level
between two cells, and selected the regions with
P<0.001 (t-test) as DMRs (24). In another study, the
statistical signiﬁcance of DMRs was deﬁned by permuta-
tion test and the empirical Bayes approach (3). In the case
of identifying DMRs from three or more samples, analysis
of variance (ANOVA) and Kruskall–Wallis test were used
respectively by Byun et al. (25) and Eckhardt et al. (13).
The use of ANOVA assumes that the data follows a
normal distribution, but this assumption is likely to be
invalid with methylation data which follows bimodal dis-
tribution (5,26). Kruskall–Wallis test, as a non-parameter
test, is more suitable for methylation data. However, since
this method utilizes the ranks of the data rather than their
original values to calculate the statistic, it may lose
numeric information of the original data such as relative
methylation degree among samples and the maximum
ﬂuctuation range for all samples. In addition to these stat-
istic approaches, two non-statistical methods were
proposed. Fan et al. identiﬁed DMRs as the regions
with both hypermethylation (>50%) and hypomethyla-
tion (<50%) among various samples (27). It is obvious
that the cut-off value 50% may induce some false
DMRs in which the methylation levels are close to 50%
in all samples. Another method derived by Rakyan et al.
identiﬁes a region as a hypermethylated T-DMR if the
methylation level of this region in a tissue is >60% and
methylation levels of this region in at least other three
somatic tissues are <40%. This method identiﬁes a region
as a hypomethylated T-DMR if the methylation level
of this region in a tissue is <40% and methylation levels
of this region in at least other three somatic tissues are
>60%.(2). In principle, the determination of tissue-speciﬁc
DMRs by this mentioned method is supposed to be
inﬂuenced by sample number, that is, the threshold
should be redeﬁned along with the sample number. In
brief, the development of DNA methylation measurement
proposes big challenges for the DMR calling methods.
Shannon entropy (28), as a quantitative measure of dif-
ference and uncertainty in a data set, has been widely
applied in quantitative biology, such as identiﬁcation of
potential drug targets (29) and tissue-speciﬁc genes (30).
To quantify methylation difference and further identify
DMRs across multiple samples, we adapted the
Shannon entropy and developed an improved approach,
quantitative differentially methylated region (QDMR).
Based on the Shannon entropy, two optimizations, pre-
processing of methylation data and adjustment of
entropy, were performed to quantify methylation differ-
ence. The application of QDMR on synthetic and bio-
logical methylation data demonstrated that QDMR can
give a reasonable quantitative measure of methylation dif-
ference across multiple samples. In order to identify
DMRs, the threshold of DMRs was determined according
to a methylation probability model which was used to
control for a degree of the random biological variability
among samples. By the threshold, QDMR can identify
T-DMRs with better performance than pervious
methods. To further determine the sample-speciﬁcity of
DMR, the categorical sample-speciﬁcity was also pre-
deﬁned according to entropy difference. To facilitate bio-
medical researchers, we developed a standalone and a
web-based version of QDMR software, which is available
at http://bioinfo.hrbmu.edu.cn/qdmr. In summary,
QDMR can be used as an effective tool for the quantiﬁ-
cation of methylation difference and identiﬁcation of
DMRs across multiple samples.
MATERIALS AND METHODS
Synthetic methylation data
We generated methylation levels, which are scaled from
0 to 1 (0=unmethylated, 1=100% methylation) across
10 samples in eight regions representing eight potential
methylation patterns (Supplementary Table S1).
Human methylation data
The genome-wide methylation data in human was down-
loaded from ftp://ftp.ebi.ac.uk/pub/software/ensembl/efg/
MeDIP-chip/ (2). This data set consists of human
genome-wide methylation proﬁles processed by Batman
(18) for 16 tissues/cells including 13 normal somatic
tissues, placenta, sperm and the GM06990 immortalized
cell line. Each region of interest (ROI) in this data set
contains 5 50-mer probes typically. For each ROI, the
methylation level in a tissue was the mean methylation
level of the probes. We selected 40 437 ROIs whose
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cells. These ROIs were used to examine the capability of
QDMR in quantiﬁcation of methylation difference and
identiﬁcation of DMRs across different tissues.
Genomic annotations
The 40437 ROIs in human were classiﬁed into seven
categories (Up2kb, 50-UTR, CodingExon, Intron,
30-UTR, Down2kb and Intergenic regions) according to
their relative positions with six gene elements based on the
Refseq gene annotation in UCSC table browser (http://
genome.ucsc.edu/cgi-bin/hgTables) (31). Seven categories
were deﬁned according to the following rules: (i) if the
centre of a ROI is located in a gene element, the ROI is
then classiﬁed into the category related to the gene
element; (ii) if the centre of a ROI is located in more
than one gene related categories, it is classiﬁed into a
category according to the following priority:
Up2kb!50-UTR!CodingExon!Intron!30-UTR!D-
own2kb and (iii) the ROIs that cannot be assigned into
any gene related category are classiﬁed into Intergenic
category. The distribution of ROIs in seven categories is
shown in Supplementary Table S2.
CpG islands in human (hg18) were predicted by
CpG_MI approach, which was developed by Su et al.
(32). CpG island shores were deﬁned as the regions
located within 2kb of CpG islands as described in
Irizarry et al.’s work (3). A total of 40437 ROIs are clas-
siﬁed into three categories (CGIsland, CGIshore and
Other) according to their relative position to CpG
islands. CGIsland category consists of the ROIs whose
centres are located within a CpG island. CGIshore
category refers to the ROIs whose centres are located in
the CpG island shores as deﬁned above, and the remaining
regions are classiﬁed into the Other category.
Gene Ontology annotations
In order to analyse the potential roles of T-DMRs in seven
genomic categories, seven gene sets were obtained accord-
ing to the following rules: (i) the genes related to the
T-DMRs in the genomic category are classiﬁed into the
same gene set; (ii) if a gene is related to T-DMRs in dif-
ferent genomic categories, it is classiﬁed into a gene set
according to the following priority: Up2kb!50-UTR!
CodingExon!Intron!30-UTR!Down2kb and (iii) if a
gene can’t be assigned into any gene set above and there is
a Intergenic T-DMR whose centre is located within 5kb
upstream or downstream of this gene, it is classiﬁed into
Intergenic gene set. we investigated the functional rele-
vance of each gene set using g:GOst in the g:proﬁler web
service (33) for the genes related to each of the seven
genome categories above. For the comparison of
T-DMRs identiﬁed by QDMR and Rakyan’s method,
we used another annotation tool to avoid preexisting
bias in the ontology terms in g:GOst. We obtained Gene
Ontology annotations for the category of ‘biological
process’ using functional annotation tools in the
DAVID Bioinformatics Resources 6.7 website (34). A
GO term is considered signiﬁcantly enriched if the
Bonferroni corrected P<0.05.
Gene expression data
Gene expression data used in this study was downloaded
from the Gene Expression Omnibus (GSE1133) (35,36).
There were only 11 tissues (B cells, CD4
+ T cells, CD8
+
T cells, liver, lung, pancreas, prostate, placenta, skeletal
muscle, uterus and whole blood) with gene expression
proﬁles that can be used for expression analysis.
Annotations of probes for hg18 were downloaded from
UCSC Genome Browser (http://genome.ucsc.edu/) (37),
and then assigned to human refseq genes (hg18). For
each probe, the expression value is the mean of
MAS5-condensed ﬂuorescence intensities in three repli-
cates per tissue. The normalized expression data using
the GCRMA algorithm were also analysed to avoid the
bias of normalization algorithm. Mean expression value
was used when multiple probes were available for a single
gene. We used the linear expression values to quantify
expression difference and identify tissue-speciﬁc differen-
tially expressed genes (T-DEGs) by ROKU method which
works on the linear expression values (38).
Histone modiﬁcation data
In this work, 20 histone methylations and 18 acetylation
modiﬁcations detected by ChIP-Seq experiments in
human CD4
+ T cells were used. These data were
obtained from Human Histone Modiﬁcation Database
(HHMD, http://bioinfo.hrbmu.edu.cn/hhmd) (39). The
histone modiﬁcation tags were mapped to tissue-speciﬁc
DMRs. And the tag count was normalized by the total
number of bases in the region and the total read number
of the given library to obtain normalized tag density (40).
Mouse methylation data
DNA methylation data of mouse (mm8) was downloaded
from ftp://ftp.broad.mit.edu/pub/papers/rrbs/
Meissner2008/ (5). This data set consists of mouse
genome-wide methylation proﬁles on approximately 1
million distinct CpG dinucleotides detected by RRBS
(17) for 18 tissues/cells. Seven adult tissues/cells (Brain,
Liver, Lung, Spleen, B cells, CD4
+ T cells and CD8
+ T
cells) were selected for this study. CpG islands of mouse
(mm8) were also predicted by CpG_MI. The methylation
level of a CpG island was estimated as the mean methy-
lation level across all CpG dinucleotides with  5-fold
coverage overlapping the same CpG island, requiring at
least ﬁve such CpG dinucleotides. We selected 9636 CpG
islands with sufﬁcient methylation data in all the seven
adult tissues/cells. The genomic categories of CpG
islands are the same as described in the human methyla-
tion data.
Quantifying methylation difference using entropy
In order to quantify methylation difference across
samples, we proposed a new method based on Shannon
entropy. Although entropy has been used previously to
identify tissue-speciﬁc genes from gene expression data
(30), we ﬁrst apply entropy to quantify methylation differ-
ence. As far as we know, methylation data has two unique
characteristics. First, in most of methylation mapping
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by continuous values with measurement scale from 0 to
1, or 0 to 100%, where 0 represents that the particular
locus is unmethylated and 1 or 100% indicates that the
particular locus is fully methylated (22). Second, methyla-
tion data follows bimodal distribution, which is different
from other biological proﬁles such as gene expression
proﬁles (26). Thus, the original entropy used to quantify
gene expression difference from gene expression data
could not be directly used to quantify DNA methylation
difference from DNA methylation data. Therefore, we
used two steps of optimization in order to adapt the
original entropy.
The methylation vector mr of region r across N samples
was deﬁned as mr ¼ð mr,1,mr,2,    ,mr,s,    ,mr,NÞ, where
mr,s represents the methylation level in sample s. The
sum of methylation levels of region r in N samples
(
P N
s¼1
mr,s) was treated as a total methylation value. The
ratio of methylation level of region r in samples relative
to the total value was deﬁned as the relative methylation
probability ps=r ¼ mr,s=
P N
s¼1
mr,s. The original Shannon
entropy HO of the region r can be calculated as
HO ¼ 
X N
s¼1
ps=r log2ðps=rÞ: ð1Þ
According to this formula, methylation levels mr,s in vector
mr determine the distribution of ps=r which further deter-
mines the value of HO. The lower HO is the greater the
methylation difference is represented across samples. The
regions with consistent methylation among all samples
were assigned high entropy. The regions speciﬁc methyla-
tion in minor samples should be assigned lower entropy.
However, as described by Kadota et al. in the development
of ROKU method (38), the original Shannon entropy is
biased towards speciﬁc high values in minor samples.
Thus, the speciﬁc hypermethylation in minor samples can
bring about low entropy while speciﬁc hypomethylation
would not. Such situations could be observed frequently
in a number of promoters that were hypomethylated only
in minor tissues, cancers or development stages. In order to
equally quantify the methylation difference of the regions
with hyper- or hypomethylation in minor samples, we
calculated a one-step Tukey biweight (Tbr) for region r as
Kadota et al. did in the development of ROKU method
(38). One-step Tukey biweight provides a robust weighted
mean that is relatively insensitive to outliers (41). The
median Mr for methylation levels in N samples of region
r was ﬁrst computed. Then, the absolute distance for each
mr,s from the median was calculated as mr,s   Mr
       . Third,
the median of the absolute distance (Sr) from Mr was
determined. For each sample s, a uniform measure of
distance from the centre was deﬁned as
ur,s ¼
mr,s   Mr
cSr+e
, ð2Þ
where c is a tuning constant (default c=5) and e is a very
small value used to avoid zero values from happening in
the denominator (default e=0.0001). A weight in each
sample was then calculated by the bisquare function:
wður,sÞ¼ ð1   u2
r,sÞ
2, jur,sj 1
0, jur,sj > 1
 
: ð3Þ
For each sample s, the weight was reduced by a function
of its distance from the median Mr. Thus outliers can be
effectively discounted by a smooth function. When methy-
lation levels are very far from the median, their weights
are reduced to zero. Finally, the one-step Tukey biweight
(Tbr) for region r was calculated as
Tbr ¼
P N
s¼1
wður,sÞ mr,s
  
P N
s¼1
wður,sÞ
: ð4Þ
The processed methylation level m0
r,s for sample s then can
be calculated by using Tbr (a weighted mean)
m0
r,s ¼ mr,s   Tbr
       : ð5Þ
The processed methylation vector m0
r ¼ð m0
r,1,m0
r,2,    ,
m0
r,s,    ,m0
r,NÞ of region r was then used to calculate
the region’s entropy as
HP ¼ 
X N
s¼1
p0
s=r log2ðp0
s=rÞ, ð6Þ
where p0
s=r ¼ m0
r,s=
P N
s¼1
m0
r,s:
However, the range of variation was considered in neither
the original Shannon entropy nor ROKU method when
they were designed for expression arrays. Therefore, these
two methods may not be appropriate for the analysis of
the methylation arrays in which methylation level ranges
from 0 to 1 (or from 0 to 100%). For example, if two
genome regions A and B exhibit the same relative methy-
lation ps/r for each mr,s, these two regions will be assigned
to the same entropy whether they have the same methyla-
tion range or not. It is possible that region A and B have
different function in affecting biological process as they
are very different in terms of methylation status. To
overcome the shortcoming of these two methods, the
entropy for each region was adjusted by a methylation
weight which was deﬁned as
wr ¼jlog2ð
maxðmr,sÞ minðmr,sÞ
MAX-MIN
+eÞj, ð7Þ
where maxðmr,sÞ and minðmr,sÞ are the max and min
methylation level of region r in all samples respectively,
and the MAX and MIN are deﬁned as the highest methy-
lation level 1 (or 100%, while the methylation level ranges
from 0 to 100%) and the lowest methylation level 0, re-
spectively, and e is a small value used to avoid zero values
in the logarithm (default e=0.0001). Then the entropy
calculated by processed methylation vector was adjusted
by weight wr as
HQ ¼ HP   wr, ð8Þ
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across multiple samples. It ranges from zero for regions
differentially methylated in a single sample with the
biggest range to log2 N   log2
1
e for regions with uni-
form methylation level in all samples considered. The
maximum value of HQ depends on the number of
samples and value e.
Determination of threshold for identiﬁcation of DMRs
Since the methylation difference of a region can be repre-
sented by HQ, this region can be deﬁned as a DMR if HQ
is lower than an appropriate threshold, otherwise, this
regions can be deﬁned as the N-DMR. In this study, we
determined the threshold for DMRs from the methylation
probability model as Schug et al. did in selecting
tissue-speciﬁcally expressed genes from gene expression
proﬁles (30). To model the effect of experimental variabil-
ity, we simulated distribution of entropy from uniformly
methylated regions. We computed the fold change
between replicate-dependent difference from the average
level across replicates and the theoretical maximum range
of methylation. The fold change follows a normal distri-
bution with mean equal to zero and some unknown,
but ‘small’, standard deviation (SD) (Supplementary
Figure S1). Therefore, the experimental variability will
be estimated by appropriate methylation levels. To
model a uniformly methylated region, we assumed that a
region exhibits an average methylation level across all
samples and then allow the methylation levels in individ-
ual samples to follow a narrow distribution of random
fold changes from the mean level. Compared with
Schug’s method, there were two major differences in
this method. First, the entropy in current work is inde-
pendent of the average methylation across all samples
because it is derived from the methylation value processed
by Tbr. Therefore, the biological variability modeled in
this approach exhibited the average methylation level
Mean ¼ 1
2ðMAX-MINÞ across all samples. Second, the
fold change between sample-dependent difference from
the average level and the theoretical maximum range of
methylation was deﬁned as
mr,s Mean
MAX-MIN. It was assumed
in this study that the fold change follows a normal distri-
bution with mean equal to zero and some unknown, but
‘small’ SD. Thus, SD can be used to indicate the degree of
the biological variation. If SD equals to zero, the methy-
lation levels in all samples will be the same, and equal to
the Mean. The larger the SD is, the greater the methylation
difference across multiple samples is. Setting SD=0.07
means a relatively small amount of variation with methy-
lation levels between 43 and 57 in 68% of the samples,
between 36 and 64 in 95% of the samples, between 29 and
71 in 99% of the samples.
Take the determination of DMR threshold for 16
samples as an example. In total 80000 (5000 16)
random values were generated from the normal distribu-
tion model with mean=0 and SD=0.07. And 5000 uni-
formly methylated regions across 16 samples were
modeled. Then entropy HQ for each of these regions was
calculated. The entropy value at P=0.05 (one-sided)
from the distribution of 5000 entropies, which was
normal, was determined as a threshold. This process
was repeated 10 times, and therefore 10 thresholds with
mean (SD) equals to 5.326 (0.022) were produced. This
mean was determined as the threshold HDMR for DMR
identiﬁcation. Regions with entropy that is lower than
HDMR are deﬁned as DMRs while remaining regions
are not differentially methylated regions (N-DMRs).
With this method, the HDMR thresholds were produced
for samples that vary in number from 2 to 100
(Supplementary Table S3).
Measurement of sample speciﬁcity for DMRs
Based on Shannon entropy theory, the increase of variable
number would reduce uncertainty, while signiﬁcant
changes in the individual variables would result in a sub-
stantial increase of uncertainty. The sample-speciﬁc
methylation levels were considered as the main individual
factors that determine the methylation differences across
samples. For the region r, the entropy HQ represents the
methylation difference across all samples. For each sample
s, the entropy HQ= s for the methylation difference across
the samples that do not include sample s can also be
calculated. Thus, the contribution of sample s to the
whole methylation difference can be reﬂected by the
entropy difference Hr=s between HQ and HQ= s which
was deﬁned as
Hr=s ¼ HQ= s   HQ: ð9Þ
When region r is speciﬁcally methylated in sample s, Hr=s
is greater than 0. To further identify hypermethylation or
hypomethylation in a region, the categorical
sample-speciﬁcity (CSr=s) was presented as
CSr=s ¼
Hr=s   signr,s, Hr=s > 0
0, Hr=s   0
 
, ð10Þ
where signr,s was the sign of the difference between methy-
lation level mr,s in sample s and the median methyla-
tion level of vector mr in region r. Thus, the absolute
value of CSr=s is then associated with Hr=s, and the
sign of CSr=s is the same as signr,s. When value in the
sample s is very close to the median, CSr=s equals to
zero. Speciﬁc hyper-methylation in sample s will have
Hr=s > 0, and since signr,s > 0, so CSr=s > 0. CSr=s
reaches its maximum when a region is relatively
high-methylated in the sample s, and decreases as either
the number of samples high-methylated in the region
r increases, or as the relative contribution of sample s to
the region’s overall pattern decreases. Similarly speciﬁc
hypo-methylation in sample s will have Hr=s > 0, and
since signr,s < 0, so CSr=s < 0. CSr=s reaches its
minimum when a region is relatively low-methylated in
the sample s, and increases as either the number of
samples low-methylated in the region r increases, or as
the relative contribution of sample s to the region’s
overall pattern decreases.
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QDMR overview
We have developed QDMR, a bioinformatic tool for
genome-wide quantitative comparisons of DNA methyla-
tion among multiple samples based on Shannon entropy
(28) (details in methods). QDMR starts from the imported
methylation data across a number of samples. It then
performs the following steps, including quantiﬁcation
of methylation difference, identiﬁcation of DMRs and
measurement of sample-speciﬁcity (Figure 1 and
Supplementary Figure S2). In the following sections, we
applied QDMR to synthetic data and experimental data
respectively to evaluate the performance of QDMR in
quantiﬁcation of methylation difference, identiﬁcation of
DMRs and measurement of sample-speciﬁcity for DMRs.
Evaluation of QDMR in quantiﬁcation of methylation
difference by synthetic data
To evaluate the performance of QDMR, we generated
eight possible synthetic methylation patterns across ten
samples which are represented by red points in Figure 2
(Supplementary Table S1). For each pattern, the methy-
lation difference was quantiﬁed by the entropy derived
from three different entropy methods, the original
entropy (HO), the entropy calculated from processed
methylation vector (HP) and the entropy derived by
QDMR (HQ). For each of the three calculation
methods, the entropy ranges from zero to the maximum
[Max(HO)=Max(HP)=log2(10)=3.32 and Max(HQ)
=log2(10) log2(1/0.0001)=44.1]. The lower the
entropy is, the greater the methylation difference across
samples is. Thus the fold change between entropy to the
maximum was used to compare the performance of three
entropy methods in quantiﬁcation of methylation
difference.
The comparative analysis demonstrated that QDMR
can provide a reasonable quantitative measure of methy-
lation difference, which is intuitive, for each of the eight
methylation difference patterns. For the pattern with con-
sistent methylation levels across samples in Figure 2A, the
entropy by each of these three methods reaches its max-
imum indicating no methylation difference. This pattern
was identiﬁed as an N-DMR by QDMR. For the pattern
with speciﬁc high methylation level in one sample and low
levels in others (Figure 2B), the fold change by QDMR
was close to 0 while those by the other two methods were
close to 0.5 and 0.3, respectively. This observation
indicated that QDMR was superior to other methods in
quantifying methylation difference for the region with
most speciﬁc methylation pattern. The similar result is
shown in the third pattern (Figure 2C). When the
number of speciﬁc samples increases, QDMR can also
quantify methylation difference for regions with large
methylation ﬂuctuation across samples (Figure 2D
and E). QDMR identiﬁed the four patterns in
Figure 2B–E as DMRs. Moreover, hypermethylation or
hypomethylation in a small ﬂuctuation range across
samples, as shown in Figures 2F and G, are considered
as N-DMRs in most methylation studies. High entropy
was obtained from all three methods. QDMR identiﬁed
this pattern as an N-DMR. However, the fold change by
QDMR was near to 0.1 while those by other two methods
reached 1 and 0.9, respectively, indicating QDMR may be
more appropriate for the regions with small but potential-
ly functional methylation difference. Furthermore, for the
pattern with consistently high methylation in half of the
samples and low methylation in the other half as shown in
Figure 2H, the fold change by QDMR was close to 0,
while those by other two methods were close to 0.8
and 1, respectively. This methylation pattern becomes
more frequent when the number of samples decreases.
The regions with this methylation pattern would be
identiﬁed as DMRs by QDMR. These results indicated
the importance of two-step optimization and the usability
of QDMR in quantifying the difference from various
methylation patterns across two or more samples.
Quantiﬁcation of methylation difference from methylation
proﬁles in 16 human tissues
The QDMR method was then applied to the human
genome-wide methylation proﬁle including 40 437
regions of interesting (ROIs) with methylation value in
all 16 tissues (2). Each region was assigned an entropy
value by QDMR based on the methylation levels for all
the tissues. Then these regions were ranked by the entropy
from low to high as shown in Figure 3A. ROIs with larger
methylation difference were in the upper region while the
consistently methylated or unmethylated regions were in
the lower region. The top 100 and bottom 100 regions
were selected for a clearer visualization and comparison
(Supplementary Tables S4 and S5). All the top 100 regions
exhibited different methylation status across all tissues
Figure 1. Overview of QDMR. In step 1, the methylation data of the
regions to be analysed should be detected in the lab or processed by
bioinformatics methods. In step 2, methylation difference across
multiple samples for each region is quantiﬁed by the adapted
entropy. In step 3, based on the quantiﬁed methylation difference,
DMRs are identiﬁed by the threshold for the corresponding sample
number. In step 4, for each DMR identiﬁed above, the
sample-speciﬁcity is measured by the categorical sample-speciﬁcity
deﬁned according to entropy difference. Finally, all results in QDMR
can be exported for further analysis.
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entially hypomethylated speciﬁcally in sperm. In contrast, all
the bottom 100 regions showed relatively invariant methyla-
tion state, especially consistent hypomethylation across
tissues (Figure 3C). In addition, entropy scores differed
signiﬁcantly among different genomic categories
(Supplementary Figure S3A). Especially, CpG islands
showed higher entropy than that of CpG island shores
and other genome regions (Supplementary Figure S3B
and C). And there is a signiﬁcant positive correlation
between entropy and ObsCpG/ExpCpG ratio
(Supplementary Figure S3D). The entropy of a genome
region can reﬂect the methylation difference across
multiple tissues, while ObsCpG/ExpCpG ratio can reﬂect
the enrichment of CpG dinucleotides in the same region. It
is indicated that the genome regions with higher CpG
density may possess more stable methylation status among
tissues, which is consistent with the results from the other
studies in DNA methylation and CpG density (2,5,15).
Overall, QDMR can provide a precise approach to
quantify methylation difference in genome regions among
different tissues.
Figure 2. Quantiﬁcation of methylation difference for various synthetic methylation patterns. Eight subgraphs (A–H) represent eight synthetic
methylation patterns, respectively. In each subgraph, original methylation data are shown as connected red dots, and the processed data by
Tukey biweight as green dots, respectively. Two blue lines represent the highest and the lowest methylation values of each region across samples,
and the distance between them represents the methylation range. HO,H P and HQ represent the original entropy, the entropy calculated from
processed methylation vector and the entropy derived by QDMR, respectively. The pattern identiﬁed as DMR by QDMR is tagged as ‘DMR’,
while that identiﬁed as N-DMR is tagged as ‘N-DMR’, above the corresponding subgraph.
PAGE 7 OF 16 Nucleic AcidsResearch, 2011, Vol.39,No. 9 e58Figure 3. Methylation heat map across 16 human tissues of regions ranked by entropy derived from QDMR. (A). Methylation heat map of all
40437 regions ranked from top to bottom by ascending entropy. The methylation levels range from 0 (green) to 100 (red). (B) Clearer methylation
heat map of the top 100 regions with the lowest entropy. The number in the last column is the entropy derived from QDMR for the region in the
same row. (C) Clearer methylation heat map of the bottom 100 regions with highest entropy.
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proﬁles by QDMR
To identify T-DMRs based on the quantiﬁed methylation
difference across 16 tissues/cells mentioned above, the
threshold HDMR =5.326 for identiﬁcation of DMRs
for the 16 samples was obtained based on methylation
probability proﬁles (details in ‘Materials and Methods’
section). Among 40437 regions, 10651 (26%) with lower
entropy value than HDMR were classiﬁed as T-DMRs
(Supplementary Table S6), while the remaining
29786 (74%) regions were deﬁned as N-DMRs. The dis-
tribution of T-DMRs and N-DMRs in seven genome
categories showed that T-DMRs were present in all
genome categories although they were less frequent than
N-DMRs (Figure 4). There were a smaller proportion of
T-DMRs in promoter than other categories, which was
consistent with the previous ﬁndings (13). Interestingly,
T-DMRs had a preference for certain chromosomes or
regions (Supplementary Figure S4). In addition, the
number of T-DMRs overlapping with CpG island shores
was 1.6-fold as that with CpG islands (36 versus
22%, P<0.0001), which was consistent with a previous
ﬁnding that most tissue-speciﬁc DNA methylation occurs
at CpG island shores rather than CpG islands (3).
Previous studies found that promoter T-DMRs are
associated with genes that are thought to function in a
tissue-speciﬁc manner (2,42). However, the role of
intragenic and intergenic T-DMRs is still not clear. We
analysed the functions of the genes related to the T-DMRs
identiﬁed by QDMR in seven genome categories. To this
end, seven non-overlapping gene sets, each of which
consists of the genes related to T-DMRs in the same
categories, was obtained (details in ‘Materials and
Methods’ section). Then the functional relevance of each
gene set was investigated using g:GOst in the g:proﬁler
web service (33) (Table 1 and Supplementary Table S7).
In addition to the genes related to promoter T-DMRs, the
genes related to intragenic T-DMRs also exhibited enrich-
ment for multicellular organismal process and cell differ-
entiation functions. The possible interpretation for this
observation could be that methylation difference in
gene-body may be related to alternative splicing (43)
which involves in transcription regulation in the develop-
ment of multicellular organisms (44). The genes related to
T-DMRs in coding exons also tend to be targeted by
miRNAs. It is well known that miRNAs also show
tissue speciﬁcity (45) and participate in determination of
cell fate (46). This unexpected ﬁnding hinted at an epigen-
etic control of gene function involving miRNAs and DNA
methylation for which supporting evidence has been
obtained by the latest study (47). Moreover, the genes
close to Intergenic T-DMRs also showed enrichment in
tissue-speciﬁc functions, for example cell fate speciﬁcation,
organ morphogenesis, and cell differentiation. It has been
veriﬁed by previous ﬁnding that methylation in Intergenic
T-DMRs regulates gene functions in association with mul-
tiple distal regulatory elements (48), such as enhancer (49),
silencer (50). It suggests that T-DMRs identiﬁed by
QDMR may have inﬂuence on those genes that partici-
pate in multicellular organismal development and cell
differentiation.
Comparison with Rakyan’s method in identiﬁcation
of DMRs
In order to evaluate the performance of QDMR in iden-
tiﬁcation of DMRs, we compared it with a counting
method developed for 16 samples by Rakyan et al. For
the same regions used in this work, Rakyan’s method
identiﬁed 6541 T-DMRs and 33896 N-DMRs
(Figure 5A). Thus, these two methods classed all ROIs
into four groups (I, II, III and IV) as shown in
Figure 5A. It was shown that the two methods were
common in identiﬁcation of most of T-DMRs and
N-DMRs for the 16 tissues. More than half (5911/
10651) of T-DMRs identiﬁed by QDMR were also
deﬁned as T-DMRs by Rakyan’s method (Figure 5A-II),
while nearly 98% (29156/29786) of the N-DMRs
identiﬁed by QDMR were also assorted as N-DMRs by
Rakyan’s method (Figure 5A-III).
However, there were also some differences in classiﬁca-
tion of the regions in groups I and IV. Group I consisted
of 630 regions deﬁned as T-DMRs by Rakyan’s method
but as N-DMR by QDMR (Figure 5A–I). The example
for this group showed little methylation difference among
16 tissues (Supplementary Figure S5–I). Group IV con-
sisted of 4740 regions as T-DMRs by QDMR but as
N-DMRs by Rakyan’s method (Figure 5A–IV). The
example for this group showed large methylation differ-
ence across 16 tissues, and speciﬁc hypermethylation and
Figure 4. Distribution of T-DMRs and N-DMRs in seven genome categories.
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(Supplementary Figure 5–IV).
To examine the methylation properties of these two
groups, we calculated the mean, range and standard devi-
ation for each region in these two groups. The mean
methylation levels of ROIs in group I were close to 50,
while those in group IV ranged from 10 to 90 (Figure 5B).
Furthermore, ROIs in group IV showed wider range
and greater standard deviation than those in group I
(Figure 5C and D). To further analyse the functional
properties of these two groups, Gene Ontology annotation
was performed at the genes related to each group. The
T-DMRs identiﬁed only by QDMR were located within
or nearby 2697 genes. These genes showed enrichment
for cellular developmental process, cell differentiation
and cell–cell adhesion in higher speciﬁcity (Table 2 and
Supplementary Table S8). Cell–cell adhesion, especially
calcium-dependent cell–cell adhesion, has a key role in
the organization of tissues comprising multiple cell types
(51). However, 388 genes related to T-DMR identiﬁed
only by Rakyan’s method did not show any functional
enrichment under the same P-value threshold
(Supplementary Table S8). Therefore, the T-DMRs
identiﬁed by QDMR may possess more unstable methyla-
tion patterns across multiple tissues. Further enrichment
analysis of the genes related with these T-DMRs suggests
that these T-DMRs may participate in biological func-
tions. Overall, QDMR provides a good performance
approach for identifying DMRs across multiple samples.
Measurement of sample speciﬁcity for DMRs by QDMR
As mentioned above, QDMR can identify functional
T-DMRs from genome-wide methylation data. Some
T-DMRs may exhibit not only methylation difference
across tissues but also speciﬁcity in a particular tissue.
To measure the tissue speciﬁcity for T-DMRs identiﬁed
by QDMR, categorical sample-speciﬁcity CSr=s was
deﬁned based on the entropy difference Hr=s (details in
‘Materials and Methods’ section). For each tissue, speciﬁc
hypermethylated T-DMRs (Hyper-T-DMRs) and speciﬁc
Table 1. Functional enrichment of genes related to T-DMRs by g:GOst
Term
type
Term name P-value Term
type
Term name P-value
Up 2kb
GOBP Multicellular organismal process 1.62E-17 GOBP System development 3.02E-06
GOBP Signal transduction 2.52E-11 GOBP Biological regulation 6.59E-06
GOBP Cell surface receptor linked signalling pathway 4.04E-09 GOCC Intermediate ﬁlament cytoskeleton 1.82E-14
50-UTR
KEGG Retinol metabolism 2.63E-04 KEGG Leukocyte transendothelial migration 5.74E-04
Coding exon
GOBP Homophilic cell adhesion 3.82E-17 KEGG Calcium signalling pathway 8.03E-07
GOBP Multicellular organismal development 9.49E-12 REAC Signalling by GPCR 2.07E-11
GOBP Cell–cell adhesion 6.91E-09 MiRNA MI:hsa-miR-886-5p 1.83E-08
GOBP Calcium-dependent cell–cell adhesion 7.48E-08 MiRNA MI:hsa-miR-663 1.96E-08
GOBP Cell morphogenesis involved in differentiation 5.89E-07 MiRNA MI:hsa-miR-339-3p 2.67E-08
GOBP Cell differentiation 1.29E-06 MiRNA MI:hsa-miR-324-3p 8.65E-08
GOMF Transcription factor activity 6.16E-06 MiRNA MI:hsa-miR-638 5.95E-06
Intron
GOBP Multicellular organismal development 2.46E-12 GOBP Regulation of cell communication 2.24E-06
GOBP Anatomical structure development 4.27E-11 GOBP Cell adhesion 2.65E-06
GOBP Multicellular organismal process 4.52E-08 GOCC Cell projection 9.83E-09
GOBP Cell differentiation 4.74E-08 GOMF Cytoskeletal protein binding 2.24E-12
GOBP Organ development 1.87E-07 GOMF Calcium ion binding 3.22E-07
30-UTR
GOCC Intracellular 1.69E-05
Down 2kb
None
Intergenic
GOBP Regulation of transcription 1.40E-21 GOBP Regulation of developmental process 2.19E-05
GOBP Regulation of gene expression GOCC Nucleus 3.70E-12
GOBP Cell fate speciﬁcation 8.96E-12 GOMF DNA binding 5.10E-21
GOBP Multicellular organismal development 2.00E-08 GOMF Nucleic acid binding 6.13E-16
GOBP Organ development 2.64E-08 GOMF Transcription regulator activity 3.58E-13
GOBP Cell fate commitment 1.11E-07 GOMF Transcription factor activity 3.73E-11
GOBP Anatomical structure development 1.35E-07 MiRNA MI:hsa-miR-615-5p 3.66E-10
GOBP Organ morphogenesis 2.97E-07 MiRNA MI:hsa-miR-339-3p 6.62E-06
GOBP Regulation of transcription from
RNA polymerase II promoter
9.34E-07 MiRNA MI:hsa-miR-663 1.05E-05
GOBP Embryonic morphogenesis 7.70E-06 MiRNA MI:hsa-miR-423-3p 4.13E-05
GOBP Cell differentiation 8.52E-06 MiRNA MI:hsa-miR-296-5p 7.11E-05
GOBP Regulation of cell differentiation 1.53E-05 MiRNA MI:hsa-miR-886-5p 1.17E-04
Term type: Annotation database and gradation. GOBP: biological process in GO; GOCC: cellular component in GO; GOMF: molecular function in
GO; KEGG: KEGG pathway; REAC: reactome pathway; MiRNA: microRNA target.
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from 10651 regions by positive and negative CSr=s, re-
spectively (Table 3 and Supplementary Table S9). The
number of tissue-speciﬁc methylated regions varied
widely among the tissues (Supplementary Figure S6).
Especially, there were more speciﬁc T-DMRs in Uterus
and Sperm suggesting the distinctive methylation
patterns in germ cell-related tissues (52). In addition, the
proportion of Hyper-T-DMRs and Hypo-T-DMRs was
also different among different tissues. For example, the
number of Hypo-T-DMRs was 2.5 times more than that
of Hyper-T-DMRs in CD4
+ T cells. Further analysis on
gene EPYC, which involves in female pregnancy,
demonstrated that the speciﬁc hypomethylation of the
T-DMR in the promoter of EPYC may account for its
speciﬁc high expression in placenta (Supplementary
Figure S7). Therefore, it is speculated that speciﬁc tissue
may possess its unique methylation patterns which deter-
mine its development and differentiation.
The relationship between histone modiﬁcation and
speciﬁc T-DMRs
Histone modiﬁcations play important roles in stem cell
maintenance and tissue differentiation (53,54). A recent
study reported the speciﬁcity of histone modiﬁcations
in lineage fate determination of differentiating CD4
+ T
cells (55). We investigated the normalized tag density of
each histone modiﬁcation in Hyper-T-DMRs and Hypo-
T-DMRs in CD4
+ T cells. The ratio between the mean
tag density in Hypo-T-DMRs and that in Hyper-T-
DMRs was deﬁned as the relative modiﬁcation intensity.
Wecomparedthetagdensities ofeachhistone modiﬁcation
between Hyper- and Hypo-T-DMRs. As shown in
Figure 6, Hypo-T-DMRs were more likely to be
overlapped with active chromatin marks, such as
H4K20me1, H3K79me3, H2BK5me1, H3K79me2,
H3K79me1, H3K4me1, H3R2me2, H3K9me1, H4K16ac
and H4K19ac, most of which correlates with active
Figure 5. Performance of QDMR in identiﬁcation of T-DMRs and N-DMRs. (A) Different categories of regions by Rakyan’s method and QDMR.
X-axis are the ROIs which are divided into two groups according Rakyan’s method, T-DMRs represented by orange dots (I and II), and N-DMRs
represented by blue dots (III and IV). Y-axis is the entropy for each ROI derived from QDMR. All 40437 regions are classiﬁed as N-DMRs (I and
III) and T-DMRs (II and IV) by DMR threshold represented by the red line. The number indicates the amount of regions in the corresponding
category. (B) The mean methylation levels across 16 tissues of the regions in I and IV. (C) The range of methylation levels in 16 tissues of the regions
in I and IV. (D) The standard deviation of methylation levels in 16 tissues of the regions in I and IV.
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mal development (56). On the contrary, Hyper-T-DMRs
were in preference in suppressive histone modiﬁcations,
such as H3K9me3, H3K27me3 and H3K27me2, most of
which are involved in pluripotency maintenance and cell
fate decisions (53). These results suggested that Hyper-T-
DMRs and Hypo-T-DMRs may correlate with histone
modiﬁcations that have different activities and functions.
The correlation between DNA methylation difference and
gene expression difference
Irizarry et al. found differential methylation across tran-
scription start sites exhibited a strong inverse relationship
with differential gene expression (3). To examine whether
this relationship is still hold genome-widely, we obtained
16258 ROIs related to 10 220 Refseq genes for 11 tissues
whose corresponding gene expressions were available in
the gene atlas data (36). We investigated the correlation
between methylation difference and expression difference
of associated genes in seven genome categories. The
methylation difference of each ROI was quantiﬁed by
the entropy derived from QDMR and the expression dif-
ference of each gene by the entropy was derived from
ROKU (38) for average expression status of related
genes of the same ROI. For ROIs in Up2kb, 50-UTR,
CodingExon and Intron, the Pearson correlation coefﬁ-
cient (PCC) between methylation entropy and expression
entropy shows that methylation difference is positively
correlated with gene expression difference
(Supplementary Figure S8). This observation is consistent
with a recent study which demonstrated that differential
DNA methylation correlates with differential expression
of angiogenic factors in human heart failure (57).
Recent studies demonstrated that T-DMRs are
associated with differences in gene expression (3,42). We
studied the locations of T-DMRs identiﬁed by QDMR
and tissue-speciﬁc differentially expressed genes
(T-DEGs) in 11 tissues. Based on the quantiﬁed methyla-
tion difference, QDMR identiﬁed 2391 T-DMRs and
13867 N-DMRs using the threshold HDMR =4.637 for
11 samples. And based on the quantiﬁed expression dif-
ference, we selected 2965 T-DEGs and 7255 N-DEGs
using the threshold HDEG =2.326 which was estimated
from probability model of gene expression as described
in Schug’s work (30). About 35.1% (840/2391) of
T-DMRs located from upstream 2000bp to downstream
2000bp of a T-DEG (Supplementary Table S10), while
only 27.5% (3813/13867) N-DMRs located from
upstream 2000bp to downstream 2000bp of a T-DEG.
Thus T-DMRs overlapped with T-DEGs much more
than expected (Chi-square test, P<0.0001,
Supplementary Table S10), which was consistent with
the ﬁnding of previous studies (3,57). For example, there
was a T-DMR in the ﬁrst intron of gene IL7R
(Supplementary Figure S9A). The hypomethylation of
this T-DMR in CD4
+ T cells and CD8
+ T cells may
involve in regulating the high expression of this gene
(Supplementary Figure S9B–D), which has been
demonstrated by Kim et al. (58). These results indicated
that T-DMRs may involve in regulation of cell/
tissue-speciﬁc gene expression which is considered as a
natural event in the tissue formation process (43).
The software package
The results have demonstrated that QDMR is useful in
quantiﬁcation of methylation difference, identiﬁcation of
DMRs and measurement of sample speciﬁcity for each
DMR. To facilitate its use in analysis of DMRs, we de-
veloped stand-alone and web-based software packages
using Java (Supplementary Figure S10). This software
includes all the features discussed in this article. It can
process data ﬁles with at least two samples with the fol-
lowing steps: data import, differentiation quantization,
Table 2. Functional enrichment of genes related to T-DMRs
identiﬁed only by QDMR based on biological process (BP)
BP term Gene
number
Bonferroni
P-value
Multicellular organismal process 789 7.56E-15
Homophilic cell adhesion 59 4.80E-13
Biological adhesion 174 7.53E-10
Cell–cell adhesion 88 1.29E-09
Cell adhesion 173 1.33E-09
Anatomical structure development 485 2.25E-09
Nervous system development 243 2.27E-09
System development 449 1.38E-08
Developmental process 575 8.33E-08
Multicellular organismal development 527 2.78E-07
System process 299 5.24E-06
Neurological system process 249 7.04E-06
Calcium-dependent cell–cell adhesion 17 1.36E-05
Cellular developmental process 314 6.18E-03
Cell differentiation 303 6.22E-03
Cell–cell signalling 128 1.67E-02
Anatomical structure morphogenesis 228 2.12E-02
Cell communication 161 2.19E-02
Synaptic transmission 73 2.25E-02
Cognition 179 3.56E-02
Neurogenesis 126 4.85E-02
Only annotations with Bonferroni P<0.05 for GO in all levels are
listed here. Full lists and more details are provided in Supplementary
Table S7.
Table 3. Speciﬁcally hyper- and hypomethylated T-DMRs across 16
human tissues
Tissue T-DMR Hyper-T-DMR (%) Hypo-T-DMR (%)
B cell 461 180 (52.7) 281 (47.3)
CD4
+ T cell 522 117 (22.4) 405 (77.6)
CD8
+ T cell 840 619 (73.7) 221 (26.3)
Cervix 478 304 (63.6) 174 (36.4)
Colon 375 181 (50.9) 194 (49.1)
Liver 1174 851 (72.5) 323 (27.5)
Lung 412 224 (54.4) 188 (45.6)
Pancreas 657 321 (48.9) 336 (51.1)
Prostate 419 220 (52.5) 199 (47.5)
Rectum 628 280 (44.6) 348 (55.4)
Skeletal muscle 1865 1614 (86.5) 251 (13.5)
Uterus 4876 2057 (42.2) 2819 (57.8)
Whole blood 926 552 (59.6) 374 (40.4)
Placenta 1170 722 (61.7) 448 (38.3)
Sperm 4079 585 (14.3) 3494 (85.7)
Gm06990 2415 1606 (66.5) 809 (33.5)
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lation visualization. Two output formats are available:
tabular and graphical. The tabular output is a table of
DMRs entries with columns representing region informa-
tion, entropy, sample speciﬁcity and raw methylation
data. The graphical output allows the user to inspect the
raw methylation data pattern, DMR distribution on
chromosomes and genome information at UCSC
Genome Browser. The standalone and online version of
QDMR is provided at http://bioinfo.hrbmu.edu.cn/qdmr.
In addition, the source code is also open to the public.
Application of QDMR to the methylation proﬁles in
mouse
Finally, QDMR software was applied to analyse the
methylation data set which was detected by RRBS in
seven adult mouse tissues/cells of 9636 CpG islands (5).
The heat map of methylation in seven tissues/cells of
mouse demonstrated that QDMR also can quantify
methylation difference for mouse methylation data
(Supplementary Figure S11A). Most CpG islands ex-
hibited consistent hypomethylation across seven tissues/
cells, which is consistent with a previous ﬁnding that
CpG islands are often free of methylation in normal
somatic tissues (59). According to the threshold
HDMR=3.636 for seven samples, only 4% (397/9636)
of CpG islands were identiﬁed as T-DMRs
(Supplementary Table S11). It is implied that CpG
islands possess less tissues/cells differential methylation
which is consistent with the ﬁnding in human genome in
this article. There were less T-DMRs than N-DMRs in
each genome category, while the CpG islands in Up2kb,
50-UTR and Intron exhibited a smaller proportion of
T-DMRs than other genome categories (Supplementary
Figure S11B). The distribution of all the T-DMRs
identiﬁed by QDMR on mouse chromosomes was also
shown in the visualization module in QDMR software
(Supplementary Figure S11C). The total 326 genes that
are related to these T-DMRs showed enrichment for
organ development (Supplementary Table S11). For
example, there is a T-DMR in the promoter of gene
HOXA5 encoding a transcription factor which plays key
roles in differentiation of adult cells (60). Previous studies
have demonstrated that the methylation of this T-DMR is
involved in regulation of cell-type-speciﬁc expression of
gene HOXA5 (61,62), which was also shown in our
analysis (Supplementary Figure S12).
DISCUSSION
Shannon entropy, as a measure of the uncertainty
associated with a random variable, has been previously
used to carry out biological research, such as to identify
potential drug targets (29), to prioritize promoter activity
(63) and to measure tissue speciﬁcity of gene expression in
many tissues (30). Due to the unique characteristics of the
methylation data, a two-step optimization was performed
based on Shannon entropy. The main difference between
QDMR and Shannon entropy is that QDMR introduces a
weight to adjust the entropy, which makes signiﬁcant im-
provement in quantiﬁcation of methylation difference. In
order to show the impact of weighting, we selected three
methylation patterns as shown in Figure 7A–C from the
data in Figure 2B divided by 2, 10 and 100, respectively.
Figure 6. Relative modiﬁcation intensity between CD4
+ T cell-speciﬁc Hyper-T-DMRs and Hypo-T-DMRs. X-axis is 38 histone modiﬁcations in
CD4
+ T cell. Y-axis is the relative modiﬁcation intensity of histone modiﬁcation between hypermethylated and hypomethylated T-DMRs. The
horizontal line represents the same modiﬁcation intensity between CD4
+ T cell-speciﬁc Hyper-T-DMRs and Hypo-T-DMRs. ‘Asterisk’ represents
those histone modiﬁcations with signiﬁcantly different modiﬁcation intensity between CD4
+ T cell-speciﬁc Hyper-T-DMRs and Hypo-T-DMRs.
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smaller ﬂuctuation range compared with region in
Figure 2B. As shown in Figure 7, when the ﬂuctuation
range of methylation becomes smaller, HQ from QDMR
becomes bigger, while both HO and HP have no change.
Therefore, the entropy adjustment process by weight plays
an important role in quantifying the methylation differ-
ence for regions with small methylation ﬂuctuation range.
This methylation pattern is very common in genomes
with numerous CpG islands which have constitutive
hypomethylation among all samples.
There are two major differences between QDMR and
the previous methods in identiﬁcation of DMRs. The ﬁrst
difference is that QDMR identiﬁes DMRs based on quan-
tiﬁed methylation difference, while previous methods
based on statistics or counting. The entropy derived
from QDMR can quantify methylation difference reason-
ably, and can reﬂect the biological characteristics of
methylation difference, such as methylation difference dis-
tribution, the relationship between methylation difference
and CpG density, and the association between methyla-
tion difference and gene expression difference. QDMR can
be used to quantify methylation difference among various
numbers of samples, which beneﬁts from the mathematic-
al properties of Shannon entropy. Moreover, the thresh-
olds determined from methylation probability model can
be used to identify DMRs based on the quantiﬁed methy-
lation difference. The second difference of QDMR is its
adaptability to the number of samples. The previous
methods were designed for the particular data set with
the given numbers of samples in their works. Instead,
QDMR was developed for identifying DMRs for variable
sample numbers. Therefore, QDMR may be a more
suitable method for identiﬁcation of DMRs from methy-
lation proﬁles with multiple samples.
QDMR is independent of speciﬁc methylation mapping
technique. Currently, nearly all of these techniques need
the pre-treatment of DNA before ampliﬁcation or hybrid-
ization by three main approaches, including endonuclease
digestion, afﬁnity enrichment and bisulphite conversion as
reviewed by Laird (22). For biological and historical
reasons, the methylation data is with measurement scale
from 0 to 1 (0=unmethylated, 1=100% methylated)
in most of methylation mapping techniques, especially
some sequencing-based techniques MethylC-Seq, RRBS,
MeDIP-seq and MSCC. QDMR works on the fraction or
percentage methylation across multiple samples, and
identiﬁes DMRs in a quantitative way, which has not
been performed by previous methylation analysis.
QDMR can be used to analyse the methylation proﬁles
from most of the current methylation mapping techniques
as summarized in Supplementary Table S12.
With the emergence of cost-effective high-throughput
sequencing techniques (for example, single-molecule
sequencing and nanopore sequencing), it may become
less expensive to proﬁle the methylation status in various
tissues and other states (9,22). The identiﬁcation of DMRs
from those high-throughput data may be the foundation
of further functional genomics analysis. In addition to the
identiﬁcation of T-DMRs, QDMR could be applied to
identify C-DMRs, D-DMRs, R-DMRs, Intra-DMRs,
Inter-DMRs and DMRs in other biological processes.
The quantiﬁcation of methylation difference and identiﬁ-
cation of DMRs in multifarious temporal and spatial
methylomes should provide comprehensive survey of
genome-wide epigenetic functions.
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Figure 7. Importance of methylation range across samples. Three regions with different methylation range across samples are artiﬁcially synthesized
based on the methylation values in Figure 2B. (A) Methylation values are produced from Figure 2B divided by 2. (B) Methylation values are
produced from Figure 2B divided by 10. (C) Methylation values are produced from Figure 2B divided by 100.
e58 Nucleic Acids Research, 2011,Vol. 39,No. 9 PAGE 14 OF 16REFERENCES
1. Bird,A. (2002) DNA methylation patterns and epigenetic memory.
Genes Dev., 16, 6–21.
2. Rakyan,V.K., Down,T.A., Thorne,N.P., Flicek,P., Kulesha,E.,
Graf,S., Tomazou,E.M., Backdahl,L., Johnson,N., Herberth,M.
et al. (2008) An integrated resource for genome-wide
identiﬁcation and analysis of human tissue-speciﬁc differentially
methylated regions (tDMRs). Genome Res., 18, 1518–1529.
3. Irizarry,R.A., Ladd-Acosta,C., Wen,B., Wu,Z., Montano,C.,
Onyango,P., Cui,H., Gabo,K., Rongione,M., Webster,M. et al.
(2009) The human colon cancer methylome shows similar hypo-
and hypermethylation at conserved tissue-speciﬁc CpG island
shores. Nat. Genet., 41, 178–186.
4. Reik,W., Dean,W. and Walter,J. (2001) Epigenetic reprogramming
in mammalian development. Science, 293, 1089–1093.
5. Meissner,A., Mikkelsen,T.S., Gu,H., Wernig,M., Hanna,J.,
Sivachenko,A., Zhang,X., Bernstein,B.E., Nusbaum,C., Jaffe,D.B.
et al. (2008) Genome-scale DNA methylation maps of pluripotent
and differentiated cells. Nature, 454, 766–770.
6. Doi,A., Park,I.H., Wen,B., Murakami,P., Aryee,M.J., Irizarry,R.,
Herb,B., Ladd-Acosta,C., Rho,J., Loewer,S. et al. (2009)
Differential methylation of tissue- and cancer-speciﬁc CpG island
shores distinguishes human induced pluripotent stem cells,
embryonic stem cells and ﬁbroblasts. Nat. Genet., 41, 1350–1353.
7. Bjornsson,H.T., Sigurdsson,M.I., Fallin,M.D., Irizarry,R.A.,
Aspelund,T., Cui,H., Yu,W., Rongione,M.A., Ekstrom,T.J.,
Harris,T.B. et al. (2008) Intra-individual change over time in
DNA methylation with familial clustering. JAMA, 299,
2877–2883.
8. Bock,C., Walter,J., Paulsen,M. and Lengauer,T. (2008)
Inter-individual variation of DNA methylation and its
implications for large-scale epigenome mapping.
Nucleic Acids Res., 36, e55.
9. Lister,R. and Ecker,J.R. (2009) Finding the ﬁfth base:
genome-wide sequencing of cytosine methylation. Genome Res.,
19, 959–966.
10. Shen,C.K. and Maniatis,T. (1980) Tissue-speciﬁc DNA
methylation in a cluster of rabbit beta-like globin genes. Proc.
Natl Acad. Sci. USA, 77, 6634–6638.
11. Kawai,J., Hirotsune,S., Hirose,K., Fushiki,S., Watanabe,S. and
Hayashizaki,Y. (1993) Methylation proﬁles of genomic DNA of
mouse developmental brain detected by restriction landmark
genomic scanning (RLGS) method. Nucleic Acids Res., 21,
5604–5608.
12. Frommer,M., McDonald,L.E., Millar,D.S., Collis,C.M., Watt,F.,
Grigg,G.W., Molloy,P.L. and Paul,C.L. (1992) A genomic
sequencing protocol that yields a positive display of
5-methylcytosine residues in individual DNA strands.
Proc. Natl Acad. Sci. USA, 89, 1827–1831.
13. Eckhardt,F., Lewin,J., Cortese,R., Rakyan,V.K., Attwood,J.,
Burger,M., Burton,J., Cox,T.V., Davies,R., Down,T.A. et al.
(2006) DNA methylation proﬁling of human chromosomes 6, 20
and 22. Nat. Genet., 38, 1378–1385.
14. Weber,M., Davies,J.J., Wittig,D., Oakeley,E.J., Haase,M.,
Lam,W.L. and Schubeler,D. (2005) Chromosome-wide and
promoter-speciﬁc analyses identify sites of differential DNA
methylation in normal and transformed human cells. Nat. Genet.,
37, 853–862.
15. Weber,M., Hellmann,I., Stadler,M.B., Ramos,L., Paabo,S.,
Rebhan,M. and Schubeler,D. (2007) Distribution, silencing
potential and evolutionary impact of promoter DNA methylation
in the human genome. Nat. Genet., 39, 457–466.
16. Lister,R., Pelizzola,M., Dowen,R.H., Hawkins,R.D., Hon,G.,
Tonti-Filippini,J., Nery,J.R., Lee,L., Ye,Z., Ngo,Q.M. et al.
(2009) Human DNA methylomes at base resolution show
widespread epigenomic differences. Nature, 462, 315–322.
17. Meissner,A., Gnirke,A., Bell,G.W., Ramsahoye,B., Lander,E.S.
and Jaenisch,R. (2005) Reduced representation bisulﬁte
sequencing for comparative high-resolution DNA methylation
analysis. Nucleic Acids Res., 33, 5868–5877.
18. Down,T.A., Rakyan,V.K., Turner,D.J., Flicek,P., Li,H.,
Kulesha,E., Graf,S., Johnson,N., Herrero,J., Tomazou,E.M. et al.
(2008) A Bayesian deconvolution strategy for
immunoprecipitation-based DNA methylome analysis. Nat.
Biotechnol., 26, 779–785.
19. Serre,D., Lee,B.H. and Ting,A.H. (2010) MBD-isolated Genome
sequencing provides a high-throughput and comprehensive survey
of DNA methylation in the human genome. Nucleic Acids Res.,
38, 391–399.
20. Ball,M.P., Li,J.B., Gao,Y., Lee,J.H., LeProust,E.M., Park,I.H.,
Xie,B., Daley,G.Q. and Church,G.M. (2009) Targeted and
genome-scale strategies reveal gene-body methylation signatures in
human cells. Nat. Biotechnol., 27, 361–368.
21. Edwards,J.R., O’Donnell,A.H., Rollins,R.A., Peckham,H.E.,
Lee,C., Milekic,M.H., Chanrion,B., Fu,Y., Su,T., Hibshoosh,H.
et al. (2010) Chromatin and sequence features that deﬁne the
ﬁne and gross structure of genomic methylation patterns.
Genome Res., 20, 972–980.
22. Laird,P.W. (2010) Principles and challenges of genome-wide DNA
methylation analysis. Nat. Rev. Genet., 11, 191–203.
23. Bock,C. and Lengauer,T. (2008) Computational epigenetics.
Bioinformatics, 24, 1–10.
24. Bibikova,M., Chudin,E., Wu,B., Zhou,L., Garcia,E.W., Liu,Y.,
Shin,S., Plaia,T.W., Auerbach,J.M., Arking,D.E. et al. (2006)
Human embryonic stem cells have a unique epigenetic signature.
Genome Res., 16, 1075–1083.
25. Byun,H.M., Siegmund,K.D., Pan,F., Weisenberger,D.J., Kanel,G.,
Laird,P.W. and Yang,A.S. (2009) Epigenetic proﬁling of somatic
tissues from human autopsy specimens identiﬁes tissue- and
individual-speciﬁc DNA methylation patterns. Hum. Mol. Genet.,
18, 4808–4817.
26. Rakyan,V.K., Hildmann,T., Novik,K.L., Lewin,J., Tost,J.,
Cox,A.V., Andrews,T.D., Howe,K.L., Otto,T., Olek,A. et al.
(2004) DNA methylation proﬁling of the human major
histocompatibility complex: a pilot study for the human
epigenome project. PLoS Biol., 2, e405.
27. Fan,S. and Zhang,X. (2009) CpG island methylation pattern in
different human tissues and its correlation with gene expression.
Biochem. Biophys. Res. Commun., 383, 421–425.
28. Shannon,C.E. (1997) The mathematical theory of communication.
MD Comput., 14, 306–317.
29. Fuhrman,S., Cunningham,M.J., Wen,X., Zweiger,G.,
Seilhamer,J.J. and Somogyi,R. (2000) The application of shannon
entropy in the identiﬁcation of putative drug targets. Biosystems,
55, 5–14.
30. Schug,J., Schuller,W.P., Kappen,C., Salbaum,J.M., Bucan,M. and
Stoeckert,C.J. Jr (2005) Promoter features related to tissue
speciﬁcity as measured by Shannon entropy. Genome Biol., 6,
R33.
31. Karolchik,D., Hinrichs,A.S., Furey,T.S., Roskin,K.M.,
Sugnet,C.W., Haussler,D. and Kent,W.J. (2004) The UCSC Table
Browser data retrieval tool. Nucleic Acids Res., 32, D493–D496.
32. Su,J., Zhang,Y., Lv,J., Liu,H., Tang,X., Wang,F., Qi,Y., Feng,Y.
and Li,X. (2010) CpG_MI: a novel approach for identifying
functional CpG islands in mammalian genomes.
Nucleic Acids Res., 38, e6.
33. Reimand,J., Kull,M., Peterson,H., Hansen,J. and Vilo,J. (2007)
g:Proﬁler–a web-based toolset for functional proﬁling of gene lists
from large-scale experiments. Nucleic Acids Res., 35, W193–W200.
34. Huang da,W., Sherman,B.T. and Lempicki,R.A. (2009) Systematic
and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat. Protoc., 4, 44–57.
35. Barrett,T., Troup,D.B., Wilhite,S.E., Ledoux,P., Rudnev,D.,
Evangelista,C., Kim,I.F., Soboleva,A., Tomashevsky,M.,
Marshall,K.A. et al. (2009) NCBI GEO: archive for
high-throughput functional genomic data. Nucleic Acids Res., 37,
D885–D890.
36. Su,A.I., Wiltshire,T., Batalov,S., Lapp,H., Ching,K.A., Block,D.,
Zhang,J., Soden,R., Hayakawa,M., Kreiman,G. et al. (2004) A
gene atlas of the mouse and human protein-encoding
transcriptomes. Proc. Natl Acad. Sci. USA, 101, 6062–6067.
37. Rhead,B., Karolchik,D., Kuhn,R.M., Hinrichs,A.S.,
Zweig,A.S., Fujita,P.A., Diekhans,M., Smith,K.E.,
Rosenbloom,K.R., Raney,B.J. et al. (2010) The UCSC Genome
Browser database: update 2010. Nucleic Acids Res., 38,
D613–D619.
PAGE 15 OF 16 Nucleic AcidsResearch, 2011, Vol.39,No. 9 e5838. Kadota,K., Ye,J., Nakai,Y., Terada,T. and Shimizu,K. (2006)
ROKU: a novel method for identiﬁcation of tissue-speciﬁc genes.
BMC Bioinformatics, 7, 294.
39. Zhang,Y., Lv,J., Liu,H., Zhu,J., Su,J., Wu,Q., Qi,Y., Wang,F.
and Li,X. (2010) HHMD: the human histone modiﬁcation
database. Nucleic Acids Res., 38, D149–D154.
40. Wang,Z., Zang,C., Rosenfeld,J.A., Schones,D.E., Barski,A.,
Cuddapah,S., Cui,K., Roh,T.Y., Peng,W., Zhang,M.Q. et al.
(2008) Combinatorial patterns of histone acetylations and
methylations in the human genome. Nat. Genet., 40, 897–903.
41. Hubbell,E., Liu,W.M. and Mei,R. (2002) Robust estimators for
expression analysis. Bioinformatics, 18, 1585–1592.
42. Yagi,S., Hirabayashi,K., Sato,S., Li,W., Takahashi,Y.,
Hirakawa,T., Wu,G., Hattori,N., Ohgane,J., Tanaka,S. et al.
(2008) DNA methylation proﬁle of tissue-dependent and
differentially methylated regions (T-DMRs) in mouse
promoter regions demonstrating tissue-speciﬁc gene expression.
Genome Res., 18, 1969–1978.
43. Laurent,L., Wong,E., Li,G., Huynh,T., Tsirigos,A., Ong,C.T.,
Low,H.M., Kin Sung,K.W., Rigoutsos,I., Loring,J. et al. (2010)
Dynamic changes in the human methylome during differentiation.
Genome Res., 20, 320–331.
44. Ernst,C., Deleva,V., Deng,X., Sequeira,A., Pomarenski,A.,
Klempan,T., Ernst,N., Quirion,R., Gratton,A., Szyf,M. et al.
(2009) Alternative splicing, methylation state, and expression
proﬁle of tropomyosin-related kinase B in the frontal cortex of
suicide completers. Arch. Gen. Psychiatr, 66, 22–32.
45. Lagos-Quintana,M., Rauhut,R., Yalcin,A., Meyer,J.,
Lendeckel,W. and Tuschl,T. (2002) Identiﬁcation of tissue-speciﬁc
microRNAs from mouse. Curr. Biol., 12, 735–739.
46. Alvarez-Garcia,I. and Miska,E.A. (2005) MicroRNA functions in
animal development and human disease. Development, 132,
4653–4662.
47. Khraiwesh,B., Arif,M.A., Seumel,G.I., Ossowski,S., Weigel,D.,
Reski,R. and Frank,W. (2010) Transcriptional control of gene
expression by microRNAs. Cell, 140, 111–122.
48. Schoenborn,J.R., Dorschner,M.O., Sekimata,M., Santer,D.M.,
Shnyreva,M., Fitzpatrick,D.R., Stamatoyannopoulos,J.A. and
Wilson,C.B. (2007) Comprehensive epigenetic proﬁling identiﬁes
multiple distal regulatory elements directing transcription of the
gene encoding interferon-gamma. Nat. Immunol., 8, 732–742.
49. Hark,A.T., Schoenherr,C.J., Katz,D.J., Ingram,R.S., Levorse,J.M.
and Tilghman,S.M. (2000) CTCF mediates methylation-sensitive
enhancer-blocking activity at the H19/Igf2 locus. Nature, 405,
486–489.
50. Klochkov,D., Rincon-Arano,H., Ioudinkova,E.S., Valadez-
Graham,V., Gavrilov,A., Recillas-Targa,F. and Razin,S.V. (2006)
A CTCF-dependent silencer located in the differentially
methylated area may regulate expression of a housekeeping gene
overlapping a tissue-speciﬁc gene domain. Mol. Cell. Biol., 26,
1589–1597.
51. Takeichi,M. (1988) The cadherins: cell-cell adhesion molecules
controlling animal morphogenesis. Development, 102, 639–655.
52. Schaefer,C.B., Ooi,S.K., Bestor,T.H. and Bourc’his,D. (2007)
Epigenetic decisions in mammalian germ cells. Science, 316,
398–399.
53. Mikkelsen,T.S., Ku,M., Jaffe,D.B., Issac,B., Lieberman,E.,
Giannoukos,G., Alvarez,P., Brockman,W., Kim,T.K., Koche,R.P.
et al. (2007) Genome-wide maps of chromatin state in pluripotent
and lineage-committed cells. Nature, 448, 553–560.
54. Heintzman,N.D., Hon,G.C., Hawkins,R.D., Kheradpour,P.,
Stark,A., Harp,L.F., Ye,Z., Lee,L.K., Stuart,R.K., Ching,C.W.
et al. (2009) Histone modiﬁcations at human enhancers reﬂect
global cell-type-speciﬁc gene expression. Nature, 459, 108–112.
55. Wei,G., Wei,L., Zhu,J., Zang,C., Hu-Li,J., Yao,Z., Cui,K.,
Kanno,Y., Roh,T.Y., Watford,W.T. et al. (2009) Global mapping
of H3K4me3 and H3K27me3 reveals speciﬁcity and plasticity in
lineage fate determination of differentiating CD4+ T cells.
Immunity, 30, 155–167.
56. Li,E. (2002) Chromatin modiﬁcation and epigenetic
reprogramming in mammalian development. Nat. Rev. Genet., 3,
662–673.
57. Movassagh,M., Choy,M.K., Goddard,M., Bennett,M.R.,
Down,T.A. and Foo,R.S. (2010) Differential DNA methylation
correlates with differential expression of angiogenic factors in
human heart failure. PLoS One, 5, e8564.
58. Kim,H.R., Hwang,K.A., Kim,K.C. and Kang,I. (2007)
Down-regulation of IL-7Ralpha expression in human T cells via
DNA methylation. J. Immunol., 178, 5473–5479.
59. Bird,A.P. (1986) CpG-rich islands and the function of DNA
methylation. Nature, 321, 209–213.
60. Garin,E., Lemieux,M., Coulombe,Y., Robinson,G.W. and
Jeannotte,L. (2006) Stromal Hoxa5 function controls the growth
and differentiation of mammary alveolar epithelium. Dev. Dyn.,
235, 1858–1871.
61. Strathdee,G., Sim,A., Soutar,R., Holyoake,T.L. and Brown,R.
(2007) HOXA5 is targeted by cell-type-speciﬁc CpG island
methylation in normal cells and during the development of acute
myeloid leukaemia. Carcinogenesis, 28, 299–309.
62. Watson,R.E., Curtin,G.M., Hellmann,G.M., Doolittle,D.J. and
Goodman,J.I. (2004) Increased DNA methylation in the HoxA5
promoter region correlates with decreased expression of the gene
during tumor promotion. Mol. Carcinog., 41, 54–66.
63. Barrera,L.O., Li,Z., Smith,A.D., Arden,K.C., Cavenee,W.K.,
Zhang,M.Q., Green,R.D. and Ren,B. (2008) Genome-wide
mapping and analysis of active promoters in mouse embryonic
stem cells and adult organs. Genome Res., 18, 46–59.
e58 Nucleic Acids Research, 2011,Vol. 39,No. 9 PAGE 16 OF 16